Strauss Borrelli PLLC, a leading data breach law firm, is investigating LivaNova, PLC regarding its recent data breach. The LivaNova data breach involved sensitive personal identifiable information and protected health information belonging to an undetermined number of individuals.
ABOUT LIVANOVA, PLC
LivaNova is a global medical technology company based in the United Kingdom. Founded in 2015, LivaNova provides innovative medical technologies, delivering life-changing improvements for both the Head and Heart.2 Today, LivaNova’s diverse product portfolio and pipeline includes advanced circulatory support, cardiopulmonary, difficult-to-treat depression, drug-resistant epilepsy, and obstructive sleep apnea.2 Headquartered in London, United Kingdom, LivaNova has locations across the world and employs over 2,500 individuals.
WHAT HAPPENED?
On November 19, 2023, LivaNova discovered that it had experienced a data breach in which sensitive personal identifiable information and protected health information in its systems may have been accessed and acquired. Through its investigation, LivaNova determined that an unauthorized actor may have accessed information around October 26, 2023. On April 25, 2024, LivaNova began notifying individuals whose information may have been impacted. The type of information potentially exposed includes:
- Name
- Social Security number
- Address
- Date of birth
- Contact information
- Medical information (e.g., treatment, condition, diagnosis, prescription, physician, medical record number, device serial number)
- Health insurance information
If you received a breach notification letter from LivaNova, PLC:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
